Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical Total Liabilities (Quarterly) : 717.30M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 717.30M |
| March 31, 2026 | 798.38M |
| December 31, 2025 | 757.43M |
| September 30, 2025 | 782.27M |
| June 30, 2025 | 885.53M |
| March 31, 2025 | 829.85M |
| December 31, 2024 | 732.36M |
| September 30, 2024 | 844.74M |
| June 30, 2024 | 797.08M |
| March 31, 2024 | 861.15M |
| December 31, 2023 | 920.95M |
| September 30, 2023 | 807.71M |
| June 30, 2023 | 804.71M |
| March 31, 2023 | 960.88M |
| December 31, 2022 | 908.55M |
| September 30, 2022 | 809.46M |
| June 30, 2022 | 871.34M |
| March 31, 2022 | 1.014B |
| December 31, 2021 | 945.02M |
| September 30, 2021 | 908.85M |
| June 30, 2021 | 775.33M |
| March 31, 2021 | 865.53M |
| December 31, 2020 | 952.67M |
| September 30, 2020 | 989.17M |
| June 30, 2020 | 961.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 983.82M |
| December 31, 2019 | 956.06M |
| September 30, 2019 | 942.70M |
| June 30, 2019 | 895.17M |
| March 31, 2019 | 890.94M |
| December 31, 2018 | 815.90M |
| September 30, 2018 | 840.18M |
| June 30, 2018 | 804.71M |
| March 31, 2018 | 948.79M |
| December 31, 2017 | 862.41M |
| September 30, 2017 | 909.54M |
| June 30, 2017 | 577.98M |
| March 31, 2017 | 924.14M |
| December 31, 2016 | 576.87M |
| September 30, 2016 | 676.34M |
| June 30, 2016 | 706.97M |
| March 31, 2016 | 848.70M |
| December 31, 2015 | 840.42M |
| September 30, 2015 | 844.86M |
| June 30, 2015 | 694.03M |
| March 31, 2015 | 764.13M |
| December 31, 2014 | 688.09M |
| September 30, 2014 | 669.68M |
| June 30, 2014 | 747.50M |
| March 31, 2014 | 484.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Eisai Co., Ltd. | 3.845B |
| Chugai Pharmaceutical Co., Ltd. | 2.598B |
| Ono Pharmaceutical Co., Ltd. | 1.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.559B |
| Shareholders Equity (Quarterly) | 1.847B |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 2.816 |
| Net Debt Paydown Yield | 0.18% |